Global Glioblastoma Multiforme Treatment Market 2018 - by Manufacturers, Regions, Type, Application, Sales, Revenue, and Forecast to 2025

  • In 2017, the global Glioblastoma Multiforme Treatment market size was  million US$ and it is expected to reach  million US$ by the end of 2025, with a CAGR of  during 2018-2025.
    
    This report focuses on the global Glioblastoma Multiforme Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Glioblastoma Multiforme Treatment development in United States, Europe and China.
    
    The key players covered in this study
        AbbVie, Inc
        Activartis GmbH
        Agenus Inc
        Arog Pharmaceuticals, Inc
        Bristol-Myers Squibb Company
        Cavion LLC
        Celldex Therapeutics Inc
        Cortice Biosciences
        Exelixis Inc
        F. Hoffmann-La Roche Ltd.
    
    Market segment by Type, the product can be split into
        Bevacizumab (Avastin)
        Carmustine (BiCNU)
        Temozolomide (Temodar and Temodal and Temcad)
    
    Market segment by Application, split into
        Hospital
        Clinic
        Others
    
    Market segment by Regions/Countries, this report covers
        United States
        Europe
        China
        Japan
        Southeast Asia
        India
        Central & South America
    
    The study objectives of this report are:
        To analyze global Glioblastoma Multiforme Treatment status, future forecast, growth opportunity, key market and key players.
        To present the Glioblastoma Multiforme Treatment development in United States, Europe and China.
        To strategically profile the key players and comprehensively analyze their development plan and strategies.
        To define, describe and forecast the market by product type, market and key regions.
    
    In this study, the years considered to estimate the market size of Glioblastoma Multiforme Treatment are as follows:
        History Year: 2013-2017
        Base Year: 2017
        Estimated Year: 2018
        Forecast Year 2018 to 2025
    For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
  • 
    1 Report Overview
        1.1 Study Scope
        1.2 Key Market Segments
        1.3 Players Covered
        1.4 Market Analysis by Type
            1.4.1 Global Glioblastoma Multiforme Treatment Market Size Growth Rate by Type (2013-2025)
            1.4.2 Bevacizumab (Avastin)
            1.4.3 Carmustine (BiCNU)
            1.4.4 Temozolomide (Temodar and Temodal and Temcad)
        1.5 Market by Application
            1.5.1 Global Glioblastoma Multiforme Treatment Market Share by Application (2013-2025)
            1.5.2 Hospital
            1.5.3 Clinic
            1.5.4 Others
        1.6 Study Objectives
        1.7 Years Considered
    
    2 Global Growth Trends
        2.1 Glioblastoma Multiforme Treatment Market Size
        2.2 Glioblastoma Multiforme Treatment Growth Trends by Regions
            2.2.1 Glioblastoma Multiforme Treatment Market Size by Regions (2013-2025)
            2.2.2 Glioblastoma Multiforme Treatment Market Share by Regions (2013-2018)
        2.3 Industry Trends
            2.3.1 Market Top Trends
            2.3.2 Market Drivers
            2.3.3 Market Opportunities
    
    3 Market Share by Key Players
        3.1 Glioblastoma Multiforme Treatment Market Size by Manufacturers
            3.1.1 Global Glioblastoma Multiforme Treatment Revenue by Manufacturers (2013-2018)
            3.1.2 Global Glioblastoma Multiforme Treatment Revenue Market Share by Manufacturers (2013-2018)
            3.1.3 Global Glioblastoma Multiforme Treatment Market Concentration Ratio (CR5 and HHI)
        3.2 Glioblastoma Multiforme Treatment Key Players Head office and Area Served
        3.3 Key Players Glioblastoma Multiforme Treatment Product/Solution/Service
        3.4 Date of Enter into Glioblastoma Multiforme Treatment Market
        3.5 Mergers & Acquisitions, Expansion Plans
    
    4 Breakdown Data by Type and Application
        4.1 Global Glioblastoma Multiforme Treatment Market Size by Type (2013-2018)
        4.2 Global Glioblastoma Multiforme Treatment Market Size by Application (2013-2018)
    
    5 United States
        5.1 United States Glioblastoma Multiforme Treatment Market Size (2013-2018)
        5.2 Glioblastoma Multiforme Treatment Key Players in United States
        5.3 United States Glioblastoma Multiforme Treatment Market Size by Type
        5.4 United States Glioblastoma Multiforme Treatment Market Size by Application
    
    6 Europe
        6.1 Europe Glioblastoma Multiforme Treatment Market Size (2013-2018)
        6.2 Glioblastoma Multiforme Treatment Key Players in Europe
        6.3 Europe Glioblastoma Multiforme Treatment Market Size by Type
        6.4 Europe Glioblastoma Multiforme Treatment Market Size by Application
    
    7 China
        7.1 China Glioblastoma Multiforme Treatment Market Size (2013-2018)
        7.2 Glioblastoma Multiforme Treatment Key Players in China
        7.3 China Glioblastoma Multiforme Treatment Market Size by Type
        7.4 China Glioblastoma Multiforme Treatment Market Size by Application
    
    8 Japan
        8.1 Japan Glioblastoma Multiforme Treatment Market Size (2013-2018)
        8.2 Glioblastoma Multiforme Treatment Key Players in Japan
        8.3 Japan Glioblastoma Multiforme Treatment Market Size by Type
        8.4 Japan Glioblastoma Multiforme Treatment Market Size by Application
    
    9 Southeast Asia
        9.1 Southeast Asia Glioblastoma Multiforme Treatment Market Size (2013-2018)
        9.2 Glioblastoma Multiforme Treatment Key Players in Southeast Asia
        9.3 Southeast Asia Glioblastoma Multiforme Treatment Market Size by Type
        9.4 Southeast Asia Glioblastoma Multiforme Treatment Market Size by Application
    
    10 India
        10.1 India Glioblastoma Multiforme Treatment Market Size (2013-2018)
        10.2 Glioblastoma Multiforme Treatment Key Players in India
        10.3 India Glioblastoma Multiforme Treatment Market Size by Type
        10.4 India Glioblastoma Multiforme Treatment Market Size by Application
    
    11 Central & South America
        11.1 Central & South America Glioblastoma Multiforme Treatment Market Size (2013-2018)
        11.2 Glioblastoma Multiforme Treatment Key Players in Central & South America
        11.3 Central & South America Glioblastoma Multiforme Treatment Market Size by Type
        11.4 Central & South America Glioblastoma Multiforme Treatment Market Size by Application
    
    12 International Players Profiles
        12.1 AbbVie, Inc
            12.1.1 AbbVie, Inc Company Details
            12.1.2 Company Description and Business Overview
            12.1.3 Glioblastoma Multiforme Treatment Introduction
            12.1.4 AbbVie, Inc Revenue in Glioblastoma Multiforme Treatment Business (2013-2018)
            12.1.5 AbbVie, Inc Recent Development
        12.2 Activartis GmbH
            12.2.1 Activartis GmbH Company Details
            12.2.2 Company Description and Business Overview
            12.2.3 Glioblastoma Multiforme Treatment Introduction
            12.2.4 Activartis GmbH Revenue in Glioblastoma Multiforme Treatment Business (2013-2018)
            12.2.5 Activartis GmbH Recent Development
        12.3 Agenus Inc
            12.3.1 Agenus Inc Company Details
            12.3.2 Company Description and Business Overview
            12.3.3 Glioblastoma Multiforme Treatment Introduction
            12.3.4 Agenus Inc Revenue in Glioblastoma Multiforme Treatment Business (2013-2018)
            12.3.5 Agenus Inc Recent Development
        12.4 Arog Pharmaceuticals, Inc
            12.4.1 Arog Pharmaceuticals, Inc Company Details
            12.4.2 Company Description and Business Overview
            12.4.3 Glioblastoma Multiforme Treatment Introduction
            12.4.4 Arog Pharmaceuticals, Inc Revenue in Glioblastoma Multiforme Treatment Business (2013-2018)
            12.4.5 Arog Pharmaceuticals, Inc Recent Development
        12.5 Bristol-Myers Squibb Company
            12.5.1 Bristol-Myers Squibb Company Company Details
            12.5.2 Company Description and Business Overview
            12.5.3 Glioblastoma Multiforme Treatment Introduction
            12.5.4 Bristol-Myers Squibb Company Revenue in Glioblastoma Multiforme Treatment Business (2013-2018)
            12.5.5 Bristol-Myers Squibb Company Recent Development
        12.6 Cavion LLC
            12.6.1 Cavion LLC Company Details
            12.6.2 Company Description and Business Overview
            12.6.3 Glioblastoma Multiforme Treatment Introduction
            12.6.4 Cavion LLC Revenue in Glioblastoma Multiforme Treatment Business (2013-2018)
            12.6.5 Cavion LLC Recent Development
        12.7 Celldex Therapeutics Inc
            12.7.1 Celldex Therapeutics Inc Company Details
            12.7.2 Company Description and Business Overview
            12.7.3 Glioblastoma Multiforme Treatment Introduction
            12.7.4 Celldex Therapeutics Inc Revenue in Glioblastoma Multiforme Treatment Business (2013-2018)
            12.7.5 Celldex Therapeutics Inc Recent Development
        12.8 Cortice Biosciences
            12.8.1 Cortice Biosciences Company Details
            12.8.2 Company Description and Business Overview
            12.8.3 Glioblastoma Multiforme Treatment Introduction
            12.8.4 Cortice Biosciences Revenue in Glioblastoma Multiforme Treatment Business (2013-2018)
            12.8.5 Cortice Biosciences Recent Development
        12.9 Exelixis Inc
            12.9.1 Exelixis Inc Company Details
            12.9.2 Company Description and Business Overview
            12.9.3 Glioblastoma Multiforme Treatment Introduction
            12.9.4 Exelixis Inc Revenue in Glioblastoma Multiforme Treatment Business (2013-2018)
            12.9.5 Exelixis Inc Recent Development
        12.10 F. Hoffmann-La Roche Ltd.
            12.10.1 F. Hoffmann-La Roche Ltd. Company Details
            12.10.2 Company Description and Business Overview
            12.10.3 Glioblastoma Multiforme Treatment Introduction
            12.10.4 F. Hoffmann-La Roche Ltd. Revenue in Glioblastoma Multiforme Treatment Business (2013-2018)
            12.10.5 F. Hoffmann-La Roche Ltd. Recent Development
    
    13 Market Forecast 2018-2025
        13.1 Market Size Forecast by Regions
        13.2 United States
        13.3 Europe
        13.4 China
        13.5 Japan
        13.6 Southeast Asia
        13.7 India
        13.8 Central & South America
        13.9 Market Size Forecast by Product (2018-2025)
        13.10 Market Size Forecast by Application (2018-2025)
    
    14 Analyst's Viewpoints/Conclusions
    
    15 Appendix
        15.1 Research Methodology
            15.1.1 Methodology/Research Approach
                15.1.1.1 Research Programs/Design
                15.1.1.2 Market Size Estimation
                12.1.1.3 Market Breakdown and Data Triangulation
            15.1.2 Data Source
                15.1.2.1 Secondary Sources
                15.1.2.2 Primary Sources
        15.2 Disclaimer
        15.3 Author Details



    List of Tables and Figures
    
        Table Glioblastoma Multiforme Treatment Key Market Segments
        Table Key Players Glioblastoma Multiforme Treatment Covered
        Table Global Glioblastoma Multiforme Treatment Market Size Growth Rate by Type 2013-2025 (Million US$)
        Figure Global Glioblastoma Multiforme Treatment Market Size Market Share by Type 2013-2025
        Figure Bevacizumab (Avastin) Figures
        Table Key Players of Bevacizumab (Avastin)
        Figure Carmustine (BiCNU) Figures
        Table Key Players of Carmustine (BiCNU)
        Figure Temozolomide (Temodar and Temodal and Temcad) Figures
        Table Key Players of Temozolomide (Temodar and Temodal and Temcad)
        Table Global Glioblastoma Multiforme Treatment Market Size Growth by Application 2013-2025 (Million US$)
        Figure Hospital Case Studies
        Figure Clinic Case Studies
        Figure Others Case Studies
        Figure Glioblastoma Multiforme Treatment Report Years Considered
        Table Global Glioblastoma Multiforme Treatment Market Size 2013-2025 (Million US$)
        Figure Global Glioblastoma Multiforme Treatment Market Size and Growth Rate 2013-2025 (Million US$)
        Table Global Glioblastoma Multiforme Treatment Market Size by Regions 2013-2025 (Million US$)
        Table Global Glioblastoma Multiforme Treatment Market Size by Regions 2013-2018 (Million US$)
        Table Global Glioblastoma Multiforme Treatment Market Share by Regions 2013-2018
        Figure Global Glioblastoma Multiforme Treatment Market Share by Regions 2013-2018
        Figure Global Glioblastoma Multiforme Treatment Market Share by Regions 2018
        Table Market Top Trends
        Table Global Glioblastoma Multiforme Treatment Revenue by Manufacturers (2013-2018) (Million US$)
        Table Global Glioblastoma Multiforme Treatment Market Share by Manufacturers (2013-2018)
        Figure Global Glioblastoma Multiforme Treatment Market Share by Manufacturers in 2018
        Table Global Glioblastoma Multiforme Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
        Table Key Players Head office and Area Served
        Table Key Players Glioblastoma Multiforme Treatment Product/Solution/Service
        Table Date of Enter into Glioblastoma Multiforme Treatment Market
        Table Mergers & Acquisitions, Expansion Plans
        Table Global Glioblastoma Multiforme Treatment Market Size by Type (2013-2018) (Million US$)
        Table Global Glioblastoma Multiforme Treatment Market Size Share by Type (2013-2018)
        Figure Global Glioblastoma Multiforme Treatment Market Size Market Share by Type (2013-2018)
        Table Global Glioblastoma Multiforme Treatment Market Size by Application (2013-2018) (Million US$)
        Table Global Glioblastoma Multiforme Treatment Market Size Share by Application (2013-2018)
        Figure Global Glioblastoma Multiforme Treatment Market Size Market Share by Application (2013-2018)
        Figure Global Glioblastoma Multiforme Treatment Revenue Market Share by Application in 2017
        Figure United States Glioblastoma Multiforme Treatment Market Size 2013-2018 (Million US$)
        Table United States Key Players Glioblastoma Multiforme Treatment Revenue (2017-2018) (Million US$)
        Table United States Key Players Glioblastoma Multiforme Treatment Market Share (2017-2018)
        Table United States Glioblastoma Multiforme Treatment Market Size by Type (2013-2018) (Million US$)
        Table United States Glioblastoma Multiforme Treatment Market Share by Type (2013-2018)
        Table United States Glioblastoma Multiforme Treatment Market Size by Application (2013-2018) (Million US$)
        Table United States Glioblastoma Multiforme Treatment Market Share by Application (2013-2018)
        Figure Europe Glioblastoma Multiforme Treatment Market Size 2013-2018 (Million US$)
        Table Europe Key Players Glioblastoma Multiforme Treatment Revenue (2017-2018) (Million US$)
        Table Europe Key Players Glioblastoma Multiforme Treatment Market Share (2017-2018)
        Table Europe Glioblastoma Multiforme Treatment Market Size by Type (2013-2018) (Million US$)
        Table Europe Glioblastoma Multiforme Treatment Market Share by Type (2013-2018)
        Table Europe Glioblastoma Multiforme Treatment Market Size by Application (2013-2018) (Million US$)
        Table Europe Glioblastoma Multiforme Treatment Market Share by Application (2013-2018)
        Figure China Glioblastoma Multiforme Treatment Market Size 2013-2018 (Million US$)
        Table China Key Players Glioblastoma Multiforme Treatment Revenue (2017-2018) (Million US$)
        Table China Key Players Glioblastoma Multiforme Treatment Market Share (2017-2018)
        Table China Glioblastoma Multiforme Treatment Market Size by Type (2013-2018) (Million US$)
        Table China Glioblastoma Multiforme Treatment Market Share by Type (2013-2018)
        Table China Glioblastoma Multiforme Treatment Market Size by Application (2013-2018) (Million US$)
        Table China Glioblastoma Multiforme Treatment Market Share by Application (2013-2018)
        Figure Japan Glioblastoma Multiforme Treatment Market Size 2013-2018 (Million US$)
        Table Japan Key Players Glioblastoma Multiforme Treatment Revenue (2017-2018) (Million US$)
        Table Japan Key Players Glioblastoma Multiforme Treatment Market Share (2017-2018)
        Table Japan Glioblastoma Multiforme Treatment Market Size by Type (2013-2018) (Million US$)
        Table Japan Glioblastoma Multiforme Treatment Market Share by Type (2013-2018)
        Table Japan Glioblastoma Multiforme Treatment Market Size by Application (2013-2018) (Million US$)
        Table Japan Glioblastoma Multiforme Treatment Market Share by Application (2013-2018)
        Figure Southeast Asia Glioblastoma Multiforme Treatment Market Size 2013-2018 (Million US$)
        Table Southeast Asia Key Players Glioblastoma Multiforme Treatment Revenue (2017-2018) (Million US$)
        Table Southeast Asia Key Players Glioblastoma Multiforme Treatment Market Share (2017-2018)
        Table Southeast Asia Glioblastoma Multiforme Treatment Market Size by Type (2013-2018) (Million US$)
        Table Southeast Asia Glioblastoma Multiforme Treatment Market Share by Type (2013-2018)
        Table Southeast Asia Glioblastoma Multiforme Treatment Market Size by Application (2013-2018) (Million US$)
        Table Southeast Asia Glioblastoma Multiforme Treatment Market Share by Application (2013-2018)
        Figure India Glioblastoma Multiforme Treatment Market Size 2013-2018 (Million US$)
        Table India Key Players Glioblastoma Multiforme Treatment Revenue (2017-2018) (Million US$)
        Table India Key Players Glioblastoma Multiforme Treatment Market Share (2017-2018)
        Table India Glioblastoma Multiforme Treatment Market Size by Type (2013-2018) (Million US$)
        Table India Glioblastoma Multiforme Treatment Market Share by Type (2013-2018)
        Table India Glioblastoma Multiforme Treatment Market Size by Application (2013-2018) (Million US$)
        Table India Glioblastoma Multiforme Treatment Market Share by Application (2013-2018)
        Figure Central & South America Glioblastoma Multiforme Treatment Market Size 2013-2018 (Million US$)
        Table Central & South America Key Players Glioblastoma Multiforme Treatment Revenue (2017-2018) (Million US$)
        Table Central & South America Key Players Glioblastoma Multiforme Treatment Market Share (2017-2018)
        Table Central & South America Glioblastoma Multiforme Treatment Market Size by Type (2013-2018) (Million US$)
        Table Central & South America Glioblastoma Multiforme Treatment Market Share by Type (2013-2018)
        Table Central & South America Glioblastoma Multiforme Treatment Market Size by Application (2013-2018) (Million US$)
        Table Central & South America Glioblastoma Multiforme Treatment Market Share by Application (2013-2018)
        Table AbbVie, Inc Company Details
        Table AbbVie, Inc Revenue in Glioblastoma Multiforme Treatment Business (2013-2018) (Million US$)
        Figure AbbVie, Inc Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2013-2018)
        Table AbbVie, Inc Recent Development
        Table Activartis GmbH Company Details
        Table Activartis GmbH Revenue in Glioblastoma Multiforme Treatment Business (2013-2018)(Million US$)
        Figure Activartis GmbH Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2013-2018)
        Table Activartis GmbH Recent Development
        Table Agenus Inc Company Details
        Table Agenus Inc Revenue in Glioblastoma Multiforme Treatment Business (2013-2018)(Million US$)
        Figure Agenus Inc Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2013-2018)
        Table Agenus Inc Recent Development
        Table Arog Pharmaceuticals, Inc Company Details
        Table Arog Pharmaceuticals, Inc Revenue in Glioblastoma Multiforme Treatment Business (2013-2018)(Million US$)
        Figure Arog Pharmaceuticals, Inc Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2013-2018)
        Table Arog Pharmaceuticals, Inc Recent Development
        Table Bristol-Myers Squibb Company Company Details
        Table Bristol-Myers Squibb Company Revenue in Glioblastoma Multiforme Treatment Business (2013-2018)(Million US$)
        Figure Bristol-Myers Squibb Company Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2013-2018)
        Table Bristol-Myers Squibb Company Recent Development
        Table Cavion LLC Company Details
        Table Cavion LLC Revenue in Glioblastoma Multiforme Treatment Business (2013-2018)(Million US$)
        Figure Cavion LLC Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2013-2018)
        Table Cavion LLC Recent Development
        Table Celldex Therapeutics Inc Company Details
        Table Celldex Therapeutics Inc Revenue in Glioblastoma Multiforme Treatment Business (2013-2018)(Million US$)
        Figure Celldex Therapeutics Inc Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2013-2018)
        Table Celldex Therapeutics Inc Recent Development
        Table Cortice Biosciences Company Details
        Table Cortice Biosciences Revenue in Glioblastoma Multiforme Treatment Business (2013-2018)(Million US$)
        Figure Cortice Biosciences Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2013-2018)
        Table Cortice Biosciences Recent Development
        Table Exelixis Inc Company Details
        Table Exelixis Inc Revenue in Glioblastoma Multiforme Treatment Business (2013-2018)(Million US$)
        Figure Exelixis Inc Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2013-2018)
        Table Exelixis Inc Recent Development
        Table F. Hoffmann-La Roche Ltd. Company Details
        Table F. Hoffmann-La Roche Ltd. Revenue in Glioblastoma Multiforme Treatment Business (2013-2018)(Million US$)
        Figure F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2013-2018)
        Table F. Hoffmann-La Roche Ltd. Recent Development
        Table Global Glioblastoma Multiforme Treatment Market Size by Regions (Million US$) 2018-2025
        Figure Global Glioblastoma Multiforme Treatment Market Size Share by Regions (2018-2025)
        Figure Global Glioblastoma Multiforme Treatment Market Size Share by Regions in 2025
        Figure United States Glioblastoma Multiforme Treatment Market Size Forecast (2018-2025)(Million USD)
        Figure Europe Glioblastoma Multiforme Treatment Market Size Forecast (2018-2025)(Million USD)
        Figure China Glioblastoma Multiforme Treatment Market Size Forecast (2018-2025)(Million USD)
        Figure Japan Glioblastoma Multiforme Treatment Market Size Forecast (2018-2025)(Million USD)
        Figure Southeast Asia Glioblastoma Multiforme Treatment Market Size Forecast (2018-2025)(Million USD)
        Figure India Glioblastoma Multiforme Treatment Market Size Forecast (2018-2025)(Million USD)
        Figure Central & South America Glioblastoma Multiforme Treatment Market Size Forecast (2018-2025)(Million USD)
        Table Global Glioblastoma Multiforme Treatment Market Size by Product (2018-2025) (Million US$)
        Figure Global Glioblastoma Multiforme Treatment Market Size by Product (2018-2025)
        Figure Global Glioblastoma Multiforme Treatment Market Size by Product in 2025
        Table Global Glioblastoma Multiforme Treatment Market Size by Application (2018-2025) (Million US$)
        Figure Global Glioblastoma Multiforme Treatment Market Size by Application (2018-2025)
        Figure Global Glioblastoma Multiforme Treatment Market Size by Application in 2025
        Table Research Programs/Design for This Report
        Figure Bottom-up and Top-down Approaches for This Report
        Figure Data Triangulation
        Table Key Data Information from Secondary Sources
        Table Key Data Information from Primary Sources